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High-frequency oscillations in scalp EEG are promising non-invasive biomarkers of epileptogenicity. However, it is unclear how
high-frequency oscillations are impacted by age in the paediatric population. We prospectively recorded whole-night scalp EEG
in 30 children and adolescents with focal or generalized epilepsy. We used an automated and clinically validated high-frequency
oscillation detector to determine ripple rates (80–250Hz) in bipolar channels. Children < 7 years had higher high-frequency
oscillation rates (P¼ 0.021) when compared with older children. The median testretest reliability of high-frequency oscillation
rates reached 100% (iqr 50) for a data interval duration of 10min. Scalp high-frequency oscillation frequency decreased
with age (r ¼ 0.558, P¼0.002), whereas scalp high-frequency oscillation duration and amplitude were unaffected. The
signal-to-noise ratio improved with age (r¼ 0.37, P¼0.048), and the background ripple band activity decreased with age
(r ¼ 0.463, P¼ 0.011). We characterize the relationship of scalp high-frequency oscillation features and age in paediatric
patients. EEG intervals of 10min duration are required for reliable measurements of high-frequency oscillation rates. This
study is a further step towards establishing scalp high-frequency oscillations as a valid epileptogenicity biomarker in this
vulnerable age group.
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Introduction
High-frequency oscillations (HFO), initially identified as
epilepsy biomarkers in the intracranial EEG of patients
undergoing presurgical evaluation for focal epilepsy, have
recently also been recorded in scalp EEG, indicating their
potential future use as non-invasive biomarkers in a
broader population of patients with epilepsy.1,2 Beyond
their use for delineating the epileptogenic zone and facili-
tating surgical decision making, HFO are currently inves-
tigated as potential biomarkers of epileptogenesis, disease
severity and treatment response.2 Novel and reliable non-
invasive EEG biomarkers are urgently required since
other biomarkers currently in clinical use, such as spikes,
lack specificity as they are sometimes recorded even in
the absence of epilepsy.3,4 Furthermore, spike rates correl-
ate with neither seizure frequency nor treatment response
in patients with epilepsy.5 A novel biomarker of epilepto-
genesis that would guide timely treatment initiation, po-
tentially even before seizure onset in selected patients, as
well as efficiently monitor treatment response is poised to
drastically change epilepsy management. Considering that
epilepsy incidence is higher in early life,6 novel bio-
markers are poised to have the largest impact in the
paediatric age group, possibly improving outcome in this
vulnerable age group.
The utility of scalp HFO as a biomarker in paediatric
epilepsy has been investigated in several recent studies
that corroborated the correlation of scalp HFO with (i)
disease severity in epileptic encephalopathies such as early
infantile epileptic encephalopathy7 and West syndrome,8,9
self-limited focal epilepsies such as Rolandic epilepsy10
and its atypical forms11 and focal structural epilepsies12;
(ii) development of CSWS (continuous sharp waves in
sleep)13–16 and (iii) seizure risk at the presence of
Rolandic spikes17 and tuberous sclerosis18 or after a first
epileptic seizure, regardless of aetiology.19 All of these
studies have included patients in a wide age range from
early childhood to adolescence. Yet the impact of age it-
self on scalp HFO characteristics, potentially of crucial
importance for further analysis, is still unclear.
The only indication of a possible age-related pattern in
scalp HFO stems from a mixed cohort of children with
(n¼ 6) and without epilepsy (n¼ 17).20 High HFO rates
occurred in children under 5 years, whereas children over
13 years showed no HFO. However, this observation of
decreasing HFO rates with age failed to reach statistical
significance,20 in line with the lack of age-dependent
changes in scalp HFO rates in a longitudinal paediatric
tuberous sclerosis study.9 The observation of age-inde-
pendent scalp HFO rates is surprising in light of the
gradually increasing power in other higher frequency
bands with age, as recently confirmed in a study of cor-
tical rhythm maturation through childhood,21 thus adding
to the controversy surrounding age-related changes in
scalp HFO rates. Furthermore, although several studies
have reported the frequency, duration and amplitude of
pathological as well as physiological HFO in intracranial
EEG,22,23 only a few studies have analysed these features
in the scalp EEG,9,20 with only a single study to date
having evaluated HFO changes with age, without finding
evidence of a correlation.9 Finally, the modification of
brain activity in various frequency bands during develop-
ment21 may impact the signal-to-noise ratio (SNR) and
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thus the detectability of scalp HFO. There are considerable
changes not only in brain physiology, but also in skull
density and thickness, all of which may modify HFO signal
characteristics, making it imperative to consider develop-
mental HFO changes for the clinical implementation of
HFOs as a reliable EEG biomarker in paediatric epilepsy.
In this study, we retrospectively analysed whole-night
video-EEG in paediatric patients with epilepsy and imple-
mented an automated HFO-detector to ensure a prospect-
ive, bias-free definition of clinically relevant HFO. We
illustrate the changes occurring throughout childhood and
adolescence on (i) scalp HFO rate and (ii) scalp HFO char-
acteristics, including frequency, duration, amplitude and
(iii) scalp HFO detectability and rate reliability. This precise
delineation of age-dependent changes in HFO features will
enhance diagnostic accuracy and facilitate the implementa-
tion of scalp HFO as an epilepsy biomarker in larger, less
selected cohorts of paediatric epilepsy patients.
Materials and methods
Patient recruitment
We prospectively enrolled 30 consecutive children and
adolescents (<18 years) with epilepsy that underwent
whole-night video-EEGs at the University Children’s
Hospital Zurich, between January and September 2020.
The clinical purpose of whole-night EEG included the dif-
ferential diagnosis of epileptic versus non-epileptic events
in patients with an established diagnosis of epilepsy
(e.g. discriminating dystonic posturing from ictal events),
determination of seizure and epilepsy syndrome classifica-
tion, and pre-surgical evaluation. Epilepsy syndromes were
classified as focal or generalized, and their aetiology as
structural or genetic,24 depending on the electroclinical cor-
relations, MRI findings and genetic results. Seizure fre-
quency, as a measure of epilepsy severity, was given as the
number of seizures per month based on long-term video-
EEG for patients with daily seizures or on seizure diaries
for patients with weekly, monthly or yearly seizures.
We selected one recording from each patient for further
analysis that fulfilled the following inclusion criteria: (i)
high sampling frequency (>1000Hz), and (ii) containing
at least 10min of N3 sleep.
The collection of patient data and the scientific analysis
were approved by and performed according to the guide-
lines and regulations of the local ethics committee
(Kantonale Ethikkommission Zürich, KEK-ZH PB-2016–
02055). All patients and their parents gave written
informed consent before participating in the study.
Scalp EEG recording and data
selection
Whole-night video-EEG was recorded with 21 electrodes
placed according to the international 10–20 system at a
1024Hz sampling rate using the MicromedV
R
EEG record-
ing system (Mogliano Veneto, Treviso, Italy). Impedances
were typically 1 kX. Sleep stages were marked according
to the American Academy of Sleep Medicine (AASM) crite-
ria by experienced neurophysiologists. Continuous spike-
and-wave during sleep (CSWS) was defined by a sharp
wave index (SWI) exceeding 85% of NREM sleep.25
We selected NREM (specifically, N3) data intervals
from the first 3 h of sleep, since pathological HFO are
less contaminated by muscle artefacts, and their rates are
higher in N3 sleep compared with other states26 and de-
crease with time spent in sleep. Scalp EEG intervals with
visible artefacts and channels with continuous interference
were excluded from further analysis. We divided the
selected data into 5-min intervals for further processing,
and only patients with more than two 5-min intervals
were considered for further analysis. We considered the
patients’ age in years as a continuous variable. For sub-
group analysis, we divided the patients into a younger
group (<7 years) and an older group (7 years).
Automated HFO detection
We first re-referenced to a bipolar montage, using all
combinations of neighbouring electrodes, which resulted
in 52 bipolar channels. With this approach, we expected
to capture the HFO activity more accurately. HFO detec-
tion was conducted with a clinically validated, automated
HFO detector that has been described in detail ear-
lier.12,27–30 In brief, the detector has three stages. Stage I
determines a baseline amplitude threshold in time inter-
vals with high Stockwell entropy (low oscillatory activity)
in the ripple band (80–250Hz). Events exceeding the
threshold are marked as events of interest (EoI). In Stage
II, we select all EoI that exhibit a high frequency peak
isolated from low frequency activity in the timefre-
quency space. In Stage III we apply the following criteria
that are specific to scalp EEG. We reject all EoI that
have an amplitude 40 mV or SNR <4 or that occurs
simultaneously in homologous channels of the two hemi-
spheres; co-occurrence was defined as partial overlap in
time. There was no further visual validation of the
events, rendering the algorithm fully automated. We con-
sidered only events in the ripple band (80–250Hz) for
further analysis.
HFO detection and analysis were performed blinded to
clinical data, and HFOs were not considered for clinical
decisions. We then controlled for the clinical plausibility
of scalp HFO by comparing the localization of the chan-
nel with the highest HFO rate with the localization of
spikes in scalp EEG and focal lesions in MRI.
HFO characterization
For each patient, we calculated the channel-wise HFO
rate by dividing the number of the detected HFOs on a
channel by the total duration of the recordings.
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To characterize the HFOs, we calculated the means of
HFO frequency, duration and amplitude for the channel
with the highest HFO rates. We define HFO frequency as
the frequency of the crest and trough waves of the HFO,
HFO duration as the duration that the Hilbert envelope
of the HFO remains above the detection threshold, and
the HFO amplitude as the highest peak-to-peak amplitude
of the HFO. We included patients with >3 HFOs in the
morphology characterization.
The SNR for each patient is calculated as the average
of the SNRs of the detected HFOs on the channel with
the highest HFO rate. The SNR of an HFO is estimated
as the signal power within the duration of the HFO div-
ided by the signal power 0.5 s before and after the HFO.
The ripple band activity (RBA) is estimated as the aver-
age of the root-mean-square values of the filtered signal
in the 80–250Hz band in the channel with the highest
HFO rate.
Statistics
We describe distributions by their median and the inter-
quartile range (iqr). We used non-parametric statistics.
For comparisons, we used the Wilcoxon rank sum and
the Wilcoxon signed rank tests. To quantify correlations,
we used Spearman’s rank correlation. Hypothesis tests
were calculated with MATLABV
R
2020a.
We modelled the HFO rate using the automatic linear
modelling function of SPSSV
R
version T26. In order to
analyse the relationship between the HFO rate and four
potential predictors, we created a simple linear model
and introduced an intercept. Considering the limited
number of data points, we used the HFO rate as depend-
ent and we chose four independent variables that we con-
sidered most relevant. We selected the logarithm of
seizure frequency, CSWS (yes, no), age (younger, older)
and RBA as predictor variables. Statistical significance
was established at P< 0.05.
Data and code availability
The raw EEG data and the HFO markings are freely
available at the OpenNeuro platform (https://openneur-
o.org/datasets/ds003555/versions/1.0.1).
The software for the detection of HFOs is freely




We included 30 patients (16 female) with focal or gener-
alized epilepsy (Table 1). The median age at the record-
ing was 6.4 years (range 0.7–17.4 years). Nine patients
had a generalized epilepsy, 5 related to a known disease
mutation; the remaining 21 had a focal epilepsy, 19 asso-
ciated with a known structural brain lesion.
The total duration of scalp EEG recordings that con-
tained N3 data intervals from the first 3 h of sleep and
was thus considered for further analysis was 1055min
with a median of 27.5min per patient (range 10–85min,
iqr 25).
HFO rates are higher in younger
children
The median HFO rate across all patients was 0.77 HFO/
min (iqr 2.6). Scalp HFO rates in younger children
(<7 years, N¼ 16, 2.4 HFO/min, iqr 3.8) were higher
than in older children (7 years, N¼ 14, 0.6 HFO/min,
iqr 0.5, Wilcoxon rank sum test, P¼ 0.021) (Fig. 1).
HFO rates did not differ significantly between focal
(0.7 HFO/min, iqr 2.4) and generalized epilepsies (1.0
HFO/min, iqr 3.1) (Wilcoxon rank sum test, P¼ 0.526).
Similarly, HFO rates did not differ significantly between
structural (0.8 HFO/min, iqr 2.8) and genetic epilepsies
(3.1 HFO/min, iqr 5.1; Wilcoxon rank sum test,
P¼ 0.240). Patients with CSWS presented the highest
HFO rates (6.1 HFO/min, iqr 4.7), regardless of
aetiology.
Scalp HFO rates showed no significant correlation with
seizure frequency in all patients (Spearman correlation,
P> 0.05) or in the subgroup of patients with focal struc-
tural epilepsy, after excluding those with CSWS and after
hemispherotomy (Spearman correlation, P> 0.05).
In the fitted linear model, the HFO rates were signifi-
cantly lower in the older age group (7 years) and in the
absence of CSWS but were not related to lower seizure
frequency. The related coefficients, t-values, confidence
intervals and significance values are presented in Table 2.
The intercept gives the HFO rate when all independent
variables are equal to 0. Therefore, in our case, the inter-
cept gives the HFO rate estimate for CSWS in the
younger age group with 0 RBA, and 1 seizure per
month. It should be noted, however, that the intercept
and its statistical significance are only theoretical values
and have limited practical importance.
Reliability of HFO detection
Finally, we calculated the test2retest reliability of the
HFO detection.
We first calculated the reliability of 10-min data inter-
vals (Fig. 2), including patients with a recording duration
>20min (N¼ 26). The overall median reliability reached
100% (iqr 50%) with a 100% reliability being reached
in 15/26 (58%) of children. For younger children
(<7 years) the median reliability also reached 100% (iqr
17%). For older children (>7 years), the median reliabil-
ity was 80% (iqr 92) but this value was not significantly
different from the younger children (Wilcoxon rank sum
test, P¼ 0.208) due to the considerably wider range.
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We then calculated the reliability of 5-min data inter-
vals, including all patients (N¼ 30). Compared with 10-
min intervals, the median reliability dropped to 93% (iqr
59) in younger, and to 33% (iqr 47) in older children
and there was a significant difference between age groups
(Wilcoxon rank sum test, P¼ 0.023). The reliability
reached 100% only in 10 cases and was worse
(Wilcoxon signed rank, P¼ 0.004) than for the 10-min
data intervals.
HFO frequency decreases with age
The impact of age on HFO characteristics, including fre-
quency, duration and amplitude is shown in Fig. 3. The
division of our cohort into those younger and older than
7 years originates in the results of our exploratory
analysis. Across patients, the median frequency was
112.6Hz (iqr 22.8), the median duration 43.5ms (iqr
14.1), and the median amplitude 20.5 mV (iqr 11.3). The
scalp HFO frequency decreased with age (Spearman’s r ¼
0.558, P¼ 0.002; Fig. 3A), whereas the HFO duration
and the HFO amplitude showed no significant correlation
with age (Fig. 3B).
The SNR improves with age
The RBA and its influence on the SNR depended on age
(Fig. 3). Across patients, the median SNR was 9.463.9
(iqr 5.5) and the median RBA was 1.3mV (iqr 0.4). The
RBA decreased with increasing age (Spearman’s r ¼
0.463, P¼ 0.011) (Fig. 3E). The SNR decreased with
the increasing RBA (Spearman’s r ¼ 0.453, P¼ 0.014)
(Fig. 3F). The SNR of scalp HFO improved with increas-
ing age (Spearman’s r¼ 0.37, P¼ 0.048) (Fig. 3D).
Discussion
To our knowledge, we are the first to illustrate develop-
mental changes in pathological scalp HFO rates and their
characteristics (frequency, duration, amplitude and SNR).
We provide evidence that scalp HFO rates decrease with
age in paediatric epilepsy, independent of seizure
Figure 1 The impact of age on scalp HFO rates in children and adolescents with epilepsy. (A) Younger children (<7 years)
showed higher scalp HFO rates than older children (7 years). Patients are numbered consecutively, as in Table 1, each depicted with a
different colour. A triangle (circle) corresponds to a focal (generalized) epileptogenic zone. Markers with red edges denote the CSWS patients.
(B) Scalp HFO rates in younger children (<7 years, N ¼ 16, 2.4 HFO/min, iqr 3.8) were higher than in older children (7 years, N ¼ 14, 0.6
HFO/min, iqr 0.5, Wilcoxon rank sum test, P ¼ 0.021).
Table 2 Parameters of the linear model for HFO rate
Variable Estimate 95% CI P-value
CSWS (yes) 6.5 4.2 to 8.8 <0.001
Age group (>7 years versus
7 years)
1.5 2.9 to 0.1 0.037
Log(seizure frequency) 0.3 0.1 to 0.7 0.171
RBA 0.4 2.8 to 2 0.749
HFO rate decreases in cases without CSWS and for those in the older age group.
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frequency. We demonstrate that reliable measures of
HFO detection can be achieved in 10-min data segments,
with values being more consistent for younger children.
We show that whilst scalp HFO frequency decreases with
age, there is no age-related effect in HFO duration and
amplitude. Finally, the SNR of scalp HFO improves with
age in paediatric epilepsy, due to the decreasing back-
ground activity power. Our observations enable the
decoding of scalp HFO signals, in a first step towards
their implementation as a valid epilepsy biomarker in a
clinical setting.
HFO rates are higher in younger
children
Scalp HFO rates were significantly higher in younger
children with epilepsy in our study, in line with the sig-
nificantly higher spike rates occurring in the younger age
group.31,32 In fact, we may hypothesize that the same
neuronal processes and conductivity changes determine
the higher scalp HFO and spike rates in the first years of
life. Moreover, our finding of decreasing HFO rates with
age is in accordance with previous observations of much
higher HFO rates in infants compared with adult
patients8,33,34 and in preschool children compared with
adolescents.20 This finding has obvious implications for
scalp HFO detection, since scalp HFO as well as spikes,
the standard non-invasive EEG biomarker, become rarer
with advancing age, thus leading to a decrease in sensitiv-
ity over time. Interestingly, scalp HFO rates did not differ
significantly depending on epilepsy classification, i.e.
between focal versus generalized or structural versus gen-
etic epilepsies. This extends previous observations from
smaller, highly selected paediatric cohorts,14 underlining
the generalizability of our findings in a wider population
of children suffering from epilepsy beyond the subgroup
with drug-resistant focal seizures. It should be, however,
noted that, in our study, we have performed an explora-
tory analysis that needs to be confirmed in a new cohort,
in whom the division at age 7 can be done a priori.
CSWS, irrespective of aetiology and seizure frequency
(i.e. presence or absence of epileptic seizures), correlated
with particularly high scalp HFO rates in our study. This
observation is in line with previous work13,15,16,35 show-
ing that epileptic encephalopathy with CSWS is associ-
ated with a considerably more abundant generation of
HFOs compared with all other types of paediatric epilep-
sies. It should be noted that, in a recent study focussing
on paediatric epilepsy with sleep-related spike activation,
the highest HFO rates occurred in relation to younger
age and presence of CSWS.16 This observation matches
our findings of higher scalp HFO rates for younger chil-
dren and those with CSWS. The abundance of patho-
logical HFO in CSWS has been linked to the disruption
of physiological brain networks at a sensitive time win-
dow for cognitive development and thus to developmen-
tal stagnation or regression.13,16
Scalp HFO rates showed no significant correlation with
seizure frequency in our unselected cohort of children
and adolescents with various epilepsy syndromes, aetiolo-
gies, and treatments. This finding stands in contrast to
the significant positive correlation of scalp HFO rates
Figure 2 Test2retest reliability of scalp HFO detection. (A) The overall median reliability reached 100% (iqr 50%) with a 100%
reliability being reached in 15/26 (58%) of children. (B) For older children (>7 years), the median reliability was 80% (iqr 92) but this value
was not significantly different from younger children (Wilcoxon rank sum test, P ¼ 0.208) due to the considerably wider range. (C) The
reliability of scalp HFO detection increased with the HFO rate (r ¼ 0.721, P < 0.001). For 15/26 patients (58%) the test2retest reliability
reached 100%. Patients are marked as in Fig. 1.
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with seizure frequency in a previous paediatric cohort with
drug-resistant focal epilepsy that underwent serial scalp
EEG recordings.12 This discrepancy may be attributed to
the high heterogeneity of our current cohort, including
patients with CSWS but only rare epileptic seizures as well
as postsurgical recordings in patients with hemispheric dis-
connections. In addition, our current study considered only
one scalp EEG recording from each patient. Longitudinal
recordings as demonstrated in our previous work,12 may
be better suited to evaluating such associations, particularly
in highly heterogeneous patient groups.
Reliability of scalp HFO detection
To confirm the reproducibility of our scalp HFO detection
and establish the reliability of our findings, we performed
a test2retest analysis, as previously developed by our
group,28 investigating the spatial profile of HFO rates
across several EEG intervals from each patient. In addition,
to counteract HFO variability due to their occurrence
according to the schedule of sleep homeostasis,26,36 we
chose to analyse only data intervals from N3 sleep.
The reliability of scalp HFO detection was significantly
higher for longer (10-min) than for shorter (5-min) EEG
Figure 3 The impact of age on scalp HFO characteristics. (A) The scalp HFO frequency across patients decreased with age (r ¼
0.558, P ¼ 0.002). (B, C) Neither the scalp HFO duration nor the scalp HFO amplitude correlated with age in our cohort. (D) The signal-
to-noise rate (SNR) of scalp HFO improved with increasing age (r ¼ 0.37, P ¼ 0.048). (E) The RBA decreased with increasing age (r ¼
0.463, P ¼ 0.011). (F) The SNR decreased with increasing RBA (r ¼ 0.453, P ¼ 0.014). Patients are marked as in Fig. 1. Stars mark
significant correlations (Spearman’s P < 0.05).
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data intervals in our study, reaching a median of 100%.
For shorter (5-min) data intervals, the reliability of scalp
HFO detection was significantly higher for younger than
for older children with epilepsy, since this measure is related
to scalp HFO rates that are significantly higher in younger
than in older children. In practical terms, while for younger
children a reasonably high reliability is reached even when
using only 5-min data intervals, for older children longer
data segments may prove indispensable. Yet, it should be
noted that the analysis of 10-min data intervals provides a
considerably higher reliability compared with the analysis of
shorter data intervals, even for the younger age group.
In this study, we only considered patients with at least
10-min data intervals for HFO detection and, based on
our findings, we postulate that this approach should suf-
fice for an accurate and consistent estimation of scalp
HFO rates in most cases. We therefore recommend to re-
cord and analyze at least 10min of N3 sleep to ensure a
reliable scalp HFO detection in paediatric epilepsy,37 cru-
cial for the implementation of this novel epilepsy bio-
marker in a clinical setting. HFO analysis requires stable
spatial profiles over time that accurately reflect network
properties, since data quality and representativity will de-
termine the validity of results.37
Scalp HFO characteristics change
with age
The scalp HFO frequency decreased significantly with age
in our study. We perceive this change within the context
of brain maturation, as previously shown for the classical
cortical rhythms of sleep EEG in early brain
development.21,32,38,39
The duration and amplitude of scalp HFO remained
unaffected by age in our study, in contrast to spikes that
reportedly feature higher amplitudes and shorter duration
in younger children.32 This finding is intriguing, since we
would expect the changes in skull thickness and conduct-
ivity with advancing age40 to result in higher signal amp-
litude attenuation in older children.
Finally, the SNR of scalp HFO improves with age in
paediatric epilepsy. This observation matches the proper-
ties of spikes that reportedly feature a higher SNR with
advancing age due to the decreasing background activity
power.23 Likewise, in our study, the improvement of
SNR with age has been shown to inversely correlate with
the decrease of RBA (Fig. 3F).
Quantitative measures for age-related changes in HFO
characteristics are crucial for guiding HFO detection and
classification both by the expert reviewer and by dedi-
cated algorithms, since the HFO detector may require dif-
ferent thresholds for different age groups.
Future directions
HFO detection in routine, non-invasive, scalp EEG
recordings has introduced a novel and exciting study
field, extending the range of patients with epilepsy that
can profit from this approach beyond those with drug-re-
sistant focal epilepsy undergoing invasive evaluation or
epilepsy surgery.12 Non-invasive biomarkers for monitor-
ing epileptogenesis, disease severity and treatment re-
sponse, such as scalp EEG, are at the forefront of current
research and appear particularly promising in the younger
age groups. Considering the importance of timely inter-
vention, particularly in early-onset epilepsy,41–45 non-in-
vasively detected HFO could serve to determine
epileptogenicity and thus seizure risk in relation to a
focal lesion, guiding the timely initiation of therapeutic
intervention. In addition, scalp HFO could serve to moni-
tor therapy response, guiding anti-seizure drug tapering
after successful drug treatment or epilepsy surgery. Scalp
HFO can drastically improve epilepsy management in the
first years of life and, thus, accomplish superior seizure
and cognitive outcomes in this vulnerable population.
Conclusion
We provide evidence that the scalp HFO rate decreases
with age in paediatric epilepsy, independent of seizure
frequency. We show that the reliability of HFO detection
is high for 10min EEG data intervals, suggesting 10min
as the minimum duration of sleep EEG recording for reli-
able HFO detection. Furthermore, we describe how the
characteristics of HFO change throughout childhood and
adolescence. This detailed insight improves the HFO in-
terpretation. Our study is a further step towards estab-
lishing scalp HFO as a valid biomarker for
epileptogenicity in the paediatric population.
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